✦ LIBER ✦

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

✍ Scribed by Ellen A.M. Schenk

Book ID: 113611965
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 438 KB
Volume: 58
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2010.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Overall Survival Analysis of a Phase

Re: Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

✍ David S. Finley; Frederic Pouliot; Allan Pantuck 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Re: Denosumab and Bone-Metastasis-Free S

Re: Denosumab and Bone-Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 115 KB

Overall Survival Benefit of Radium-223 C

Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)

✍ C. Parker; D. Heinrich; J.M. O'Sullivan; S. Fossa; A. Chodacki; T. Demkow; A. Cr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Association of Rash With Outcomes in a R

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

✍ Mark T. Fleming; Guru Sonpavde; Michael Kolodziej; Sanjay Awasthi; Thomas E. Hut 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 434 KB

705 ABIRATERONE ACETATE PLUS LOW-DOSE PR

705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY

✍ Saad, Fred; de Bono, Johann S.; Haqq, Christopher M.; Logothetis, Christopher J. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

Final safety and efficacy analysis of th

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB